Market Closed - London S.E. 11:35:01 2024-04-19 am EDT 5-day change 1st Jan Change
961.8 GBX -0.52% Intraday chart for Smith & Nephew Plc +0.06% -10.82%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates MT
Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal MT
Smith+Nephew, Navbit Sign Distribution Deal for Hip Replacement Surgical Navigation System in Australia MT
Smith & Nephew Says UK NICE Reaffirms Guidance on Pico Wound Dressing MT
Miach Orthopaedics Inc. announced that it has received $50 million in funding from a group of investors CI
Smith+Nephew Introduces the RENASYS EDGE Negative Pressure Wound Therapy System CI
London stocks round off March quarter with healthy gains RE
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday MT
Smith & Nephew CFO designate John Rogers to start next week AN
Smith & Nephew CFO to Take Office in April MT
Smith & Nephew plc Announces CFO Changes CI
Smith & Nephew plc Announces Board Changes CI
Smith & Nephew Signs Up as Official Partner for UFC MT
Smith+Nephew Teams Up with Ufc to Be First-Ever Preferred Sports Medicine Technology Partner CI
Smith & Nephew prices USD1 billion in debt notes AN
Smith & Nephew plc Completes the Pricing of Usd 350,000,000 5.150% Notes Due 2027 and Usd 650,000,000 5.400% Notes Due 2034 CI
Smith & Nephew Prices Offering of Notes due 2027, 2034 MT
UK's Smith & Nephew Mulls Raising Pay for US Execs MT
Jefferies says buy BP; UBS says buy Compass AN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat MT
SMITH & NEPHEW : Strong ‘proof of execution’ to end FY23 Alphavalue
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
Smith & Nephew Signs Research Deal With US Army Institute of Surgical Research MT
Barclays Lifts Smith & Nephew PT, Maintains Equalweight Rating MT
Berenberg, JPMorgan raise price target for IHG AN
Chart Smith & Nephew Plc
More charts
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.05 USD
Average target price
16.43 USD
Spread / Average Target
+36.34%
Consensus
  1. Stock Market
  2. Equities
  3. SN. Stock
  4. News Smith & Nephew Plc
  5. Smith & Nephew Unveils New Robotic-Assisted System for Knee Surgery